One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Sinus Dilation Devices Market

[ 英語タイトル ] Sinus Dilation Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0084189
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 113
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Acclarent, Inc.
- Creganna
- Intersect ENT, Inc.
- Johnson & Johnson
- Medtronic Plc
- Meril Life Sciences Private Limited
- Olympus Corporation
- SinuSys Corporation
- Smith & Nephew
- Stryker Corporation

[Report Description]

The Global Sinus Dilation Devices market is expected to witness a CAGR of 8.8% during the forecast period. Certain factors that are driving the market growth include a rising preference for minimally invasive procedures, technological advancements, and new product launch, and increasing prevalence of sinusitis.

Chronic rhinosinusitis (CRS) is a relevant and prevalent medical condition all across the world. If analyzed in detail, the prevalence of CRS shows regional and temporary variety. Sinusitis is defined as an inflammation of the tissue that lines the sinus cavity. Sinusitis is very common. In some cases, the swelling (inflammation) completely blocks the sinuses, trapping mucus, and air inside. The trapped mucus can turn into bacterial sinus infections and result in a variety of symptoms. The rising prevalence of the disease is expected to drive the Sinus Dilation Devices market over the forecast period.

Key Market Trends

Balloon Sinus Dilation Device is Expected to Hold Significant Market Share in the Product Segment

Balloon Sinus Dilation (BSD) is an advanced surgical procedure used to treat sinusitis and other related problems through minimally invasive techniques. a relatively new technique for performing sinus surgery. The concept of using a balloon to widen the sinus openings was inspired by the use of balloons to dilate arteries during angioplasty. The technique is safe and minimally invasive since it does not result in tissue or bone removal. Patients can benefit from less bleeding and shorter recovery times with balloon sinus dilation.

North America Dominates the Market and Expected to do Same in the Forecast Period

Over the past decade, the prevalence of sinusitis in North America has increased. Commonly cited estimates from the National Health Interview Survey rank chronic sinusitis as one of the most prevalent chronic diseases in the United States. However, majority of these data rely on patient self-reporting of the disease. Also, chronic sinusitis is difficult to diagnose because its symptoms overlap those of many other disease processes. But due to the increasing awareness regarding various disorders related to sinus and the technological advancements in the sinus dilation devices are expected to propel the market growth across the region over the forecast period.

Competitive Landscape

The global Sinus Dilation Devices market is moderately competitive and consists of a few major players. Companies like Acclarent, Inc., Creganna, Intersect ENT, Inc., Johnson & Johnson Services, Inc., Medtronic, Meril Life Sciences Private Limited, Olympus Corporation, SinuSys Corporation, Smith & Nephew, Stryker, among others, hold the substantial market share in the Sinus Dilation Devices market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Preference for Minimally Invasive Procedures
4.2.2 Technological Advancements and New Product Launch
4.2.3 Increasing Prevalence of Sinusitis
4.3 Market Restraints
4.3.1 Risks Associated with Sinus Surgeries
4.3.2 Lack of Skilled Specialists
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Balloon Sinus Dilation Devices
5.1.2 Sinus Implants
5.1.3 Handheld Instruments
5.1.4 Endoscopes
5.1.5 Other Products
5.2 By Procedure
5.2.1 Standalone Sinus Dilation Procedures
5.2.2 Hybrid Sinus Dilation Procedures
5.3 By End-User
5.3.1 Hospital
5.3.2 Specialty Clinic
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Acclarent, Inc.
6.1.2 Creganna
6.1.3 Intersect ENT, Inc.
6.1.4 Johnson & Johnson
6.1.5 Medtronic Plc
6.1.6 Meril Life Sciences Private Limited
6.1.7 Olympus Corporation
6.1.8 SinuSys Corporation
6.1.9 Smith & Nephew
6.1.10 Stryker Corporation




Recommended reports